Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Dalton

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Personalized Medicine|February 25, 2022
Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance ProgramKendra J Grande, Rachel Dalton, Nicolas A Moyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 8, 2018
Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a modelSeung-Been Lee, Marsha M Wheeler, Karynne Patterson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 11, 2023
Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health centerEmily J Cicali, Amanda Elchynski, Cameron D Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2013
Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquatSarah E Lacher, Julia N Gremaud, Kasse Skagen, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural YouthJack W Staples, Shayna R Killam, Karen E Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 PathwayRavand Samaeekia, Valery Adorno-Cruz, Jessica Bockhorn, et al.
Breast Cancer Research and Treatment|December 11, 2012
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.
Cell Reports|November 11, 2025
Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNSErin Fahey, Lucia Celkova, Valentina Frezza, et al.
Clinical and Translational Science|January 27, 2021
Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele functionAlison E Fohner, Rachel Dalton, Kasse Skagen, et al.
Nature Communications|January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Personalized Medicine|February 25, 2022
Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance ProgramKendra J Grande, Rachel Dalton, Nicolas A Moyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 8, 2018
Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a modelSeung-Been Lee, Marsha M Wheeler, Karynne Patterson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 11, 2023
Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health centerEmily J Cicali, Amanda Elchynski, Cameron D Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2013
Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquatSarah E Lacher, Julia N Gremaud, Kasse Skagen, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural YouthJack W Staples, Shayna R Killam, Karen E Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 PathwayRavand Samaeekia, Valery Adorno-Cruz, Jessica Bockhorn, et al.
Breast Cancer Research and Treatment|December 11, 2012
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.
Cell Reports|November 11, 2025
Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNSErin Fahey, Lucia Celkova, Valentina Frezza, et al.
Clinical and Translational Science|January 27, 2021
Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele functionAlison E Fohner, Rachel Dalton, Kasse Skagen, et al.
Nature Communications|January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Pageof 3